Bristol Myers Squibb and Hengrui Pharma Announce Strategic Agreements to Advance Innovative Medicines in Deal Worth $15.2 billion
On May 12, 2026, Bristol Myers Squibb and Hengrui Pharma announced the companies have entered into global strategic…
-
-
Fujirebio announces CE marking of Lumipulse® G pTau 217 Plasma assay for Alzheimer’s disease
On May 11, 2026, Fujirebio Europe announced that it has obtained a CE certificate of the Lumipulse G…
-
California Dairy Study Raises New Questions About How H5N1 Spreads
On May 8, 2026, researchers detected infectious H5N1 virus in milking parlor air and wastewater systems while also…
-
Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion USD
On May 7, 2026, Angelini Pharma and Catalyst Pharmaceuticals, a commercial-stage biopharmaceutical company focused on in-licensing, developing, and…
-
Thousands of previously unknown proteins discovered
On May 6, 2026, a group of international researchers announced they had discovered 1,700 new proteins. The research…
-
Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility
On May 6, 2026, Eli Lilly announced an additional $4.5 billion investment across two of its three Lebanon…
-
UVA Study Reveals How New Weight-Loss Drugs Reshape the Brain
On May 6, 2026, In a study published in Nature, a team led by University of Virginia (UVA)…
-
USC launches transformational AI initiative with $200 million gift
On May 5, 2026, the University of Southern California (USC) announced a transformational initiative that will leverage AI…
-
Study Reports unprecedented view of the immune system’s killer cells
On May 4, 2026, a study conducted by the University of Geneva and the Lausanne University Hospital (CHUV)…
-
Amgen Announces Additional $300 Million Manufacturing Investment in Juncos, PR
On May 4, 2026, Amgen announced plans to invest an additional $300 million in its U.S. manufacturing network…
-
UCB to acquire Candid Therapeutics for more Than $2 Bllion, building upon its existing immunology pipeline
On May 3, 2026, UCB, a global biopharmaceutical company, announced signing of a definitive agreement under which it…
-
Canada approves second generic semaglutide, the first G7 country to do so
On May 1, 2026, Health Canada authorized a second generic semaglutide injection. Health Canada is currently reviewing seven other…
-
Researchers create groundbreaking first-draft map of genetic interactions within human cells
On Apr. 30, 2026, researchers at the University of Bonn and University Hospital Bonn have created a groundbreaking…
-
Biotechnology | Cloning | CRISPR | Genomics | Veterinary
Colossal Biosciences Is Working to Bring Back the Bluebuck, an Antelope Hunted to Extinction in 1800
On Apr. 30, 2026, Colossal Biosciences, the world’s de-extinction company, announced that it is working to de-extinct the…
-
Dr. Reddy’s Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
On Apr. 29, 2026, Dr. Reddy’s Laboratories announced that it has received a Notice of Compliance (NOC) from…
-
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Neurology | Non-Profit Research | Oncology | Therapeutics
Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biolog
On Apr. 29, 2026, Biohub announced the Virtual Biology Initiative, a landmark five-year initiative to galvanize a global…
-
Scientists Create First-Ever ‘Smell Map’
On Apr. 28, 2026, scientists Sandeep (Robert) Datta, professor of neurobiology in the Blavatnik Institute at Harvard Medical…
-
Mayo Clinic study points to changes decades before Alzheimer’s symptoms
On Apr. 28, 2026, new research from the Mayo Clinic show subtle biological changes linked to Alzheimer’s disease…
-
Biotechnology | Diagnostics | FDA | Neurology
U.S. FDA Grants Breakthrough Device Designation to Laguna Diagnostics’ mRNA Gene Biomarker Test to Aid in Differentiation of Schizophrenia and Bipolar I Disorder
On Apr. 28, 2026, Laguna Diagnostics announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough…
-
Sun Pharma, India’s Largest drug Firm to Buy U.S., to Acquire Organon for $11.75 Billion
On Apr. 27, 2026, Sun Pharmaceutical Industries and Organon announced they have entered into an agreement under which…
-
Princeton scientists make 3D bio-electronic hybrid system using brain cells
On Apr. 24, 2026, researchers at Princeton University announce they have developed a 3-dimensional device that merges living…
-
UK Trials Show Paxlovid speeds recovery, but doesn’t reduce hospitalization in vaccinated patients
On Apr. 23, 2026. two national trials published in the New England Journal of Medicine report Paxlovid (nirmatrelvir-ritonavir)…
-
Girl’s sight restored after ‘life-changing’ gene therapy
On Apr. 23, 2026, a research team at the University College London (UCL) and Great Ormond Street Hospital…
-
CU Medicine reveals interplay between epigenetic changes and gut microbiome in newborns with neurodevelopment later in life
On Apr. 23, 2026, a multidisciplinary research team from the Chinese University of Hong Kong’s Faculty of Medicine…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss
On Apr. 23, 2026, the U.S. Food and Drug Administration (FDA) approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual…
-
Researchers Develop DNA-Based Bio-Transistor Enabling Molecular Computation and Memory
On Apr. 22, 2026, the Korea Advanced Institute of Science and Technology (KAIST) announced that a research team…
-
U.S. Military Makes Flu Vaccine Optional
On Apr. 21, 2026, the annual influenza vaccines are no longer mandatory, said Pete Hegseth in a video…
-
Lilly to acquire Kelonia Therapeutics for $3.25 billion to advance in vivo CAR-T cell therapies
On Apr. 20, 2026, Eli Lilly and Kelonia Therapeutics, a clinical-stage biotechnology company pioneering in vivo gene delivery,…
-
Kailera nets $625M, biotech’s biggest-ever IPO
On Apr. 17, 2026, Kailera Therapeutics, a high-profile drug startup aiming to compete with Novo Nordisk and Eli…
-
Cancer Center at Illinois Earns Prestigious National Cancer Institute Designation
On Apr. 16, 2026, the Cancer Center at Illinois (CCIL) announced it has been designated as a Basic…
